Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting
Nausea and Vomiting, Postoperative
About this trial
This is an interventional prevention trial for Nausea and Vomiting, Postoperative
Eligibility Criteria
Inclusion Criteria: Patients aged 18 to 60 years ASA physical status I-II Scheduled for ureteroscopic procedure With more than one Risk factor for PONV (female, history of PONV, non-smoking). Exclusion Criteria: Patients with contraindications for spinal anesthesia including infection at the injection site, bleeding diathesis, known left ventricular outflow obstruction, hypovolemia, and increased intracranial pressure. History of allergy or hypersensitivity to propofol or dexmedetomidine. Gastrointestinal diseases e.g. gastroenteritis and gastric ulcers, ear diseases e.g. infections of middle and inner ear, liver cirrhosis. Those who have received antiemetic drugs within 48 hours before surgery. Operations lasting more than two hours. The patient's unwillingness.
Sites / Locations
- Kasralaini Medical SchoolRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Propofol group
Dexmedetomidine group
will receive propofol infusion.
will receive dexmedetomidine infusion.